1H NMR-Based Metabolomics Reveals Refined-Huang-Lian-Jie-Du-Decoction (BBG) as a Potential Ischemic Stroke Treatment Drug With Efficacy and a Favorable Therapeutic Window

• Autori principali: Xiaowei Fu (Autore), Junsong Wang (Autore), Shanting Liao (Autore), Yan Lv (Autore), Dingqiao Xu (Autore), Minghua Yang (Autore), Lingyi Kong (Autore)
• Natura: Libro
• Pubblicazione: Frontiers Media S.A., 2019-04-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Huang-Lian-Jie-Du-Decoction (HLJDD) is a traditional Chinese medicine (TCM) used to treat ischemic stroke. However, the complexity of its chemical composition makes quality control difficult. Berberine, baicalin, and geniposide are the three main ingredients in HLJDD. Here, a formula of BBG comprise...